Subscribe to RSS
DOI: 10.1055/s-0032-1320781
Metabolomic manipulation of marine fungi through epigenetic modification via histone deacetylase inhibition
Recent studies have shown marine fungi to be interesting targets of natural product investigation due to their ability to be grown under a variety of conditions that alter secondary metabolite production. Epigenetic modification via the histone deacetylase (HDAC) inhibitor sodium butyrate has been shown to increase production of metabolites of interest as well as previously unidentified compounds. In the spring of 2012, a collection of endophytic fungi was isolated from Florida mangroves. Crude extracts of these isolates were submitted for bioassay against infectious diseases including malaria and methicillin resistant Staphylococcus aureus (MRSA). This study illustrates examples in which modified versus unmodified extracts yielded both differing bioassay results and metabolomics profiles.